The effects of two weeks of recombinant growth hormone administration on the response of IGF-I and N-terminal pro-peptide of collagen type III (P-III-NP) during a single bout of high resistance exercise in resistance trained young men

Growth Hormone and IGF Research

Volumn 23, Issue 3, 2013, Pages 76-80

  Velloso, C P ^a,b   Aperghis, M ^a   Godfrey, R ^c   Blazevich, A J ^c,e   Bartlett, C ^b   Cowan, D ^b   Holt, R I G ^d   Bouloux, P ^a   Harridge, S D R ^a,b   Goldspink, G ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c BRUNEL UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^e EDITH COWAN UNIVERSITY   (Australia)

Author keywords

Anti doping; Growth hormone; IGF I; P III NP; Resistance exercise

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; PLACEBO; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C;

ADULT; ARTICLE; ATHLETE; CORRELATION ANALYSIS; EXERCISE INTENSITY; EXERCISE TEST; HORMONE ACTION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; RESISTANCE TRAINING; WEIGHT LIFTING;

ADOLESCENT; ADULT; ATHLETES; CASE-CONTROL STUDIES; COLLAGEN TYPE III; DOUBLE-BLIND METHOD; EXERCISE; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; RESISTANCE TRAINING; WEIGHT LIFTING; YOUNG ADULT;

EID: 84876707208     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2013.01.002     Document Type: Article

References (29)

1. Woodhouse L.J., Mukherjee A., Shalet S.M., Ezzat S. The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults. Endocr. Rev. 2006, 27:287-317.
2. Holt R.I., Sönksen P.H. Growth hormone, IGF-I and insulin and their abuse in sport. Br. J. Pharmacol. 2008, 154:542-556.
3. Rickert V.I., Pawlak-Morello C., Sheppard V., Jay M.S. Human growth hormone: a new substance of abuse among adolescents?. Clin. Pediatr. 1992, 31:723-726.
4. Meinhardt U., Nelson A.E., Hansen J.L., et al. The effects of growth hormone on body composition and physical performance in recreational athletes: a randomized trial. Ann. Intern. Med. 2010, 152:568-577.
5. Giannoulis M.G., Sonksen P.H., Umpleby M., et al. The effects of growth hormone and/or testosterone in healthy elderly men: a randomized controlled trial. J. Clin. Endocrinol. Metab. 2006, 91:477-484.
6. Graham M.R., Baker J.S., Evans P., et al. Short-term recombinant human growth hormone administration improves respiratory function in abstinent anabolic-androgenic steroid users. Growth Hormon. IGF Res. 2007, 17:328-335.
7. Rennie M. Claims for the anabolic effects of growth hormone: a case of the Emperor's new clothes?. Br. J. Sports Med. 2003, 37:100-105.
8. Gibney J., Healy M.L., Sonksen P.H. The growth hormone/insulin-like growth factor-I axis in exercise and sport. Endocr. Rev. 2007, 28:603-624.
9. Velloso C.P. Regulation of muscle mass by growth hormone and IGF-I. Br. J. Pharmacol. 2008, 154:557-568.
10. Liu H., Bravata D.M., Olkin I., et al. Systematic review: the effects of growth hormone on athletic performance. Ann. Intern. Med. 2008, 148:747-758.
11. Clemmons D.R., Smith-Banks A., Underwood L.E. Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans. J. Clin. Endocrinol. Metab. 1992, 75:234-238.
12. Kupfer S.R., Underwood L.E., Baxter R.C., Clemmons D.R. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously. J. Clin. Invest. 1993, 91:391-396.
13. Healy M.L., Gibney J., Russell-Jones D.L., et al. High dose growth hormone exerts an anabolic effect at rest and during exercise in endurance-trained athletes. J. Clin. Endocrinol. Metab. 2003, 88:5221-5226.
14. Godfrey R.J., Madgwick Z., Whyte G.P. The exercise-induced growth hormone response in athletes. Sports Med. 2003, 33:599-613.
15. Wu Z., Bidlingmaier M., Strasburger C.J. Detection of doping with human growth hormone. Lancet 1999, 353:895.
16. Travis J. Growth hormone test finally nabs first doper. Science 2010, 327:1185.
17. Aperghis M., Velloso C.P., Hameed M., et al. Serum IGF-I levels and IGF-I gene splicing in muscle of healthy young males receiving right. Growth Hormon. IGF Res. 2009, 19:61-67.
18. Dall R., Longobardi S., Ehrnborg C., et al. The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. J. Clin. Endocrinol. Metab. 2000, 85:4193-4200.
19. Wallace J.D., Cuneo R.C., Baxter R., et al. Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: a potential test for GH abuse in sport. J. Clin. Endocrinol. Metab. 1999, 84:3591-3601.
20. Buckway C.K., Guevara-Aguirre J., Pratt K.L., Burren C.P., Rosenfeld R.G. The IGF-I generation test revisited: a marker of GH sensitivity. J. Clin. Endocrinol. Metab. 2001, 86:5176-5183.
21. Wallace J.D., Cuneo R.C., Lundberg P.A., et al. Responses of markers of bone and collagen turnover to exercise, growth hormone (GH) administration, and GH withdrawal in trained adult males. J. Clin. Endocrinol. Metab. 2000, 85:124-133.
22. Powrie J.K., Bassett E.E., Rosen T., et al. Detection of growth hormone abuse in sport. Growth Hormon. IGF Res. 2007, 17:220-226.
23. Erotokritou-Mulligan I., Bassett E.E., Kniess A., Sonksen P.H., Holt R.I.G. Validation of the growth hormone (GH)-dependent marker method of detecting GH abuse in sport through the use of independent data sets. Growth Hormon. IGF Res. 2007, 17:416-423.
24. Erotokritou-Mulligan I., Bassett E.E., Cowan D., et al. The influence of ethnicity on insulin like growth factor-I and procollagen III peptide in elite athletes and its effect on the ability to detect GH abuse. Clin. Endocrinol. (Oxf.) 2009, 70:161-168.
25. Ehrnborg C., Lange K.H., Dall R., J.S., et al. The growth hormone/insulin-like growth factor-I axis hormones and bone markers in elite athletes in response to a maximum exercise test. J. Clin. Endocrinol. Metab. 2003, 88:394-401.
26. Erotokritou-Mulligan I., Bassett E.E., Cowan D.A., et al. The use of growth hormone (GH)-dependent markers in the detection of GH abuse in sport: physiological intra-individual variation of IGF-I, type 3 pro-collagen (P-III-P) and the GH-2000 detection score. Clin. Endocrinol. (Oxf.) 2010, 72:520-526.
27. Holt R.I., Erotokritou-Mulligan I., McHugh C., et al. The GH-2004 project: the response of IGF1 and type III pro-collagen to the administration of exogenous GH in non-Caucasian amateur athletes. Eur. J. Endocrinol. 2010, 163:45-54.
28. Erotokritou-Mulligan I., Bassett E.E., Bartlett C., et al. The effect of sports injury on insulin-like growth factor-I and type 3 procollagen: implications for detection of growth hormone abuse in athletes. J. Clin. Endocrinol. Metab. 2008, 93:2760-2763.
29. Nelson A.E., Meinhardt U., Hansen J.L., et al. Pharmacodynamics of growth hormone abuse biomarkers and the influence of gender and testosterone: a randomized double-blind placebo-controlled study in young recreational athletes. J Clin. Endocrinol. Metab. 2008, 93:2213-2222.